Kristina Burow
Director at Scholar Rock Holding; Director at Beam Therapeutics; 10% owner at Sana Biotechnology. Based in Cambridge, Massachusetts.
- Rank
- 12281st of 14,644
- Companies held
- 3
- Largest holding
- SRRK, 91.1% of total
- Latest SEC filing
- Jul 1, 2026
- Listed but not counted
- $232M
What the $6.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Scholar Rock Holding SRRK Common Stock | Directly | 114,657 | $50.37 | $5.8M | 91.1% | Form 4, Jul 1, 2026 |
| Beam Therapeutics BEAM Common Stock | Directly | 26,011 | $20.94 | $545K | 8.6% | Form 4, Jun 6, 2023 |
| Neumora Therapeutics NMRA Common Stock | Directly | 47,717 | $0.35 | $17K | 0.3% | Form 4, Oct 27, 2025 |
Share counts are the amounts Kristina Burow reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Kristina Burow's filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Scholar Rock Holding SRRK Common Stock | Through ARCH Venture Fund VIII, L.P. Held by a company or fund the insider manages | 2,345,711 | $50.37 | $118M | — | Form 4, Jul 1, 2026 |
| Beam Therapeutics BEAM Common Stock | Through ARCH Venture Fund IX Overage, L.P. Held by a company or fund the insider manages | 2,721,519 | $20.94 | $57.0M | — | Form 4, Jun 6, 2023 |
| Sana Biotechnology SANA Common Stock | Through ARCH Venture Fund X, L.P. Held by a company or fund the insider manages | 12,446,022 | $1.74 | $21.7M | — | Form 4, Feb 8, 2024 |
| Sana Biotechnology SANA Common Stock | Through AVP IX LP Held by a company or fund the insider manages | 10,667,387 | $1.74 | $18.6M | — | Form 4, Feb 8, 2024 |
| Neumora Therapeutics NMRA Common Stock | Through ARCH Venture Fund X, L.P. Held by a company or fund the insider manages | 12,205,379 | $0.35 | $4.2M | — | Form 4, Oct 27, 2025 |
| Neumora Therapeutics NMRA Common Stock | Through ARCH Venture Fund X Overage, L.P. Held by a company or fund the insider manages | 11,886,758 | $0.35 | $4.1M | — | Form 4, Oct 27, 2025 |
| Boundless Bio BOLD Common Stock | Indirectly (see filing footnote) Held by a company or fund the insider manages | 1,181,766 | $2.38 | $2.8M | — | Form 4, Apr 2, 2024 |
| Neumora Therapeutics NMRA Common Stock | Through ARCH Venture Fund XII, L.P. Held by a company or fund the insider manages | 6,046,907 | $0.35 | $2.1M | — | Form 4, Oct 27, 2025 |
| Boundless Bio BOLD Common Stock | Through AVP IX LP Held by a company or fund the insider manages | 683,759 | $2.38 | $1.6M | — | Form 4, Apr 2, 2024 |
| Neumora Therapeutics NMRA Common Stock | Through ARCH Venture Fund VIII Overage, L.P. Held by a company or fund the insider manages | 2,321,566 | $0.35 | $806K | — | Form 4, Oct 27, 2025 |
| Neumora Therapeutics NMRA Common Stock | Through ARCH Venture Fund VII, L.P. Held by a company or fund the insider manages | 1,387,228 | $0.35 | $481K | — | Form 4, Oct 27, 2025 |
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 12278 | Darius Shahida Chief Strategy/Bus Dev Officer, Butterfly Network. Guilford, CT | $6.3M |
| 12279 | Anthony Mancini See Remarks, Revolution Medicines. Redwood City, CA | $6.3M |
| 12280 | Charles John Koch Director, Citizens Financial Group. Stamford, CT | $6.3M |
| 12281 | Kristina Burow Director, Scholar Rock Holding. Cambridge, MA | $6.3M |
| 12282 | Michael C Skarke EVP & Chief Commercial Officer, Select Water Solutions. Gainesville, TX | $6.3M |
| 12283 | Susan D. Kronick Director, Hyatt Hotels. Chicago, IL | $6.3M |
| 12284 | Melina E. Higgins Director, Viatris. Glen Allen, VA | $6.3M |
Other Scholar Rock Holding insiders
All SRRK insiders- David Hallal$92.9MChief Executive Officer. #1578 overall
- Akshay Vaishnaw$31.8MPresident of R&D. #3318 overall
- Keith Woods$31.2MChief Operating Officer. #3662 overall
- Vikas Sinha$31.2MChief Financial Officer. #3539 overall
- Nagesh K. Mahanthappa$24.2MInterim CEO and President. #4489 overall
- Jay Backstrom$21.4MCHIEF EXECUTIVE OFFICER. #4912 overall
Questions
How much stock does Kristina Burow own?
Kristina Burow holds $6,336,501 in listed stock based on SEC filings and current prices, mostly Scholar Rock Holding (SRRK). That ranks 12281st on the Stock Rich List.
Is this Kristina Burow's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Kristina Burow last buy or sell stock?
The most recent open-market trade on file is a sale of 2,105 SRRK shares on Jul 1, 2026 at $53.49.
Files jointly with Keith Crandell, SEC filer 1219043, SEC filer 1229592.